Susquehanna International Group’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
HAIM
YAG
WN
VF
MAWA
IWA
BCM
Susquehanna International Group's TRIB Position: Q1 2026 in Review
Susquehanna International Group sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 475 shares — an estimated $10.5K sold.
Susquehanna International Group first reported a position in TRIB in Q3 2013 and held it in 24 quarters. The position peaked at $1.02M in Q2 2014. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.
- Susquehanna International Group reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 475 Trinity Biotech shares in Q1 2026, an estimated $10.5K.
- Susquehanna International Group first reported a position in Trinity Biotech in Q3 2013 and held it in 24 quarters.
- Susquehanna International Group's Trinity Biotech position peaked at $1.02M in Q2 2014.
- 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.